All
Immunotherapy Combo May ‘Potentially Cure’ Melanoma With Brain Metastases
November 18th 2021The combination of Opdivo and Yervoy may provide a survival benefit for asymptomatic patients with melanoma who have brain metastases, although more efforts are needed to include this patient population in trials.
There’s Always Hope After an ‘Incurable’ Cancer Diagnosis, Thanks to Devoted Researchers
November 18th 2021A cancer survivor explains how the new treatments coming out for all types of cancer give her hope. “If we are diagnosed today, a cure or remission may come out next week or next month, or next year to give us additional time to live,” she writes.
Certain Cancer Immunotherapies May Lead to ‘Potential Small Risk’ for Myocarditis
November 17th 2021Although the risk for myocarditis related to immune checkpoint inhibitors is an estimated 1%, findings from a recent study highlight the need for improved ways to screen and treat for this potential side effect.
Several Factors May Impact a Waldenstrom’s Macroglobulinemia Treatment Decision
November 16th 2021Without a huge difference in efficacy between many of the available treatments for Waldenstrom’s macroglobulinemia, one expert says patients and their clinicians should look to other factors when deciding which regimen is best.
Men With Prostate Cancer After Surgery May Benefit From Shorter Duration of Radiation Therapy
November 15th 2021Hypofractionated radiation for nearly five weeks in men with prostate cancer after surgery may have similar results without added side effects compared with radiation therapy for a standard duration of seven weeks.